can you drink alcohol while using semaglutide and GLP-1 Medications: Safety Guidelines Semaglutide as a promising new

This first month worked very well for appetite suppression, not so much weight loss

Available evidence comes primarily from observational reports and mechanistic studies rather than large randomized controlled trials, so provider clinical judgment remains central to decision-making

In October 2023, a study was published that found GLP1s triple the risk of the stomach paralysis among users when compared to users of non-injectable weight loss drugs, igniting a rapid rise in litigation against Novo Nordisk and the makers of similar other weight loss and diabetes drugs from the same class of medications

Biomedicines (2021)

But how do you reverse prediabetes